Helius Market Cap from 2010 to 2024

HSDT Stock  USD 0.49  0.03  6.52%   
Helius Medical Market Cap yearly trend continues to be comparatively stable with very little volatility. Market Cap will likely drop to about 4.6 M in 2024. From the period from 2010 to 2024, Helius Medical Market Cap quarterly data regression had r-value of (0.74) and coefficient of variation of  34.60. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
4.9 M
Current Value
4.6 M
Quarterly Volatility
4.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Market Cap Growth Pattern

Below is the plot of the Market Cap of Helius Medical Technologies over the last few years. It is Helius Medical's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Helius Market Cap Regression Statistics

Arithmetic Mean13,351,472
Geometric Mean12,143,813
Coefficient Of Variation34.60
Mean Deviation3,597,497
Median15,804,311
Standard Deviation4,619,852
Sample Variance21.3T
Range11.7M
R-Value(0.74)
Mean Square Error10.4T
R-Squared0.55
Significance0
Slope(764,816)
Total Sum of Squares298.8T

Helius Market Cap History

20244.6 M
20234.9 M
20224.1 M
202112.8 M

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as Market Cap, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Market Cap4.9 M4.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.